TherapeuticsMD
(NASDAQ) TXMD
TherapeuticsMD Financials at a Glance
Market Cap
$23.15M
Revenue (TTM)
$3.02M
Net Income (TTM)
$569.00K
EPS (TTM)
$-0.05
P/E Ratio
-40.57
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$2.02
Volume
734
Open
$2.00
Price
$2.02
Volume
734
Open
$2.00
Previous Close
$2.02
Daily Range
$1.96 - $2.02
52-Week Range
$0.84 - $2.95
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$2.02
Volume
734
Open
$2.00
Previous Close
$2.02
Daily Range
$1.96 - $2.02
52-Week Range
$0.84 - $2.95
TXMD News
3 Drug Stocks That Could Soar in 2020
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TherapeuticsMD
Industry
Pharmaceuticals
Sector
Health CareEmployees
1
CEO
Marlan D. Walker
Website
www.therapeuticsmd.comHeadquarters
Boca Raton, FL 33431, US
TXMD Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-1%
Net Income Margin
-19%
Return on Equity
-2%
Return on Capital
-13%
Return on Assets
-2%
Earnings Yield
-2.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.15M
Shares Outstanding
11.57M
Volume
734
Short Interest
0.00%
Avg. Volume
74.62K
Financials (TTM)
Gross Profit
$3.02M
Operating Income
$4.39M
EBITDA
$3.02M
Operating Cash Flow
$2.45M
Capital Expenditure
$0.00
Free Cash Flow
$2.45M
Cash & ST Invst.
$7.48M
Total Debt
$5.12M
TherapeuticsMD Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$893.00K
+33.9%
Gross Profit
$893.00K
+33.9%
Gross Margin
100.00%
N/A
Market Cap
$23.15M
N/A
Market Cap/Employee
$23.15M
N/A
Employees
1
N/A
Net Income
$619.00K
-345.6%
EBITDA
$2.26M
-965.6%
Quarterly Fundamentals
Net Cash
$2.36M
+211.6%
Accounts Receivable
$3.52M
-1.0%
Inventory
$0.00
N/A
Long Term Debt
$5.12M
-7.6%
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.51%
N/A
Return on Invested Capital
-13.36%
N/A
Free Cash Flow
$1.37M
+11350.0%
Operating Cash Flow
$1.37M
+11350.0%